Researchers built a reliable breath collection and analysis method using thermo-desorption gas chromatography-mass spectrometry (TD-GC–MS) that can produce a comprehensive list of known volatile organic compounds (VOCs) in the breath of a heterogeneous human population.
A recent study presented a novel methodology combining robust breath and background collection which analytically distinguished breath volatile organic compounds (VOCs) from background contamination, as well as VOC identification against chemical standards. The researchers, who usedthermo-desorption gas chromatography-mass spectrometry (TD-GC–MS) in their efforts, demonstrated the capability of their method by presenting a list of high-confidence breath VOCs identified from a heterogeneous human population. An article dealing with this research has been published in Metabolomics.
Although metabolomic studies primarily focus on aqueous metabolites in samples such as blood, urine, and feces, breath is a rich and diverse matrix containing thousands of different VOCs (2,3). While the non-invasive nature of breath sampling makes it particularly attractive for clinical applications, such as early diagnosis and ongoing longitudinal monitoring, the validation of clinically useful breath biomarkers remains limited, likely due, at least in part, to the lack of consistent methodologies and quality controls across the breath research literature (4,5). To advance the field of breath analysis, an urgent need is present to develop a robust platform able to accurately identify the VOCs considered to be genuinely originating from the breath, as well as to distinguish these VOCs from those in the background VOCs arising from sampling equipment, as well as surrounding air inhaled immediately by the testing subject before sampling and are thus unrelated to underlying physiology.The team carrying out this research believed that an accurate and repeatable methodology would expedite identification and validation of VOC biomarkers of disease in future studies (1).
Following the analysis of 90 adult breath samples, the authors reported their method to be a success, producing a list of 148 on-breath VOCs, identified using purified chemical standards in a heterogenous population. The data confirmed that VOC identities that are genuinely breath-borne will facilitate future biomarker discovery and subsequent biomarker validation in clinical studies. In addition, the list of VOCs generated can be used to facilitate cross-study data comparisons for improved standardization (1).
It is the hope of the authors to expand the list to include a broad range of populations and physiologies to capture the diversity of on-breath VOCs. By continuing to compare background samples collected and analyzed in the same manner as their breath samples, the team believes that the VOCs able to be confidently identified as being on-breath can be the basis for future biomarker investigations (1).
References
1. Arulvasan, W.; Chou, H.; Greenwood, J. et al. High-Quality Identification of Volatile Organic Compounds (VOCs) Originating from Breath. Metabolomics 2024, 20. DOI: 10.1007/s11306-024-02163-6
2. Costello, B. L.; Amann, A.; Al-Kateb, H.; Flynn, C.; Filipiak, W.; Khalid, T.; Osborne, D.; Ratcliffe, N. M. (2014). A Review of the Volatiles from the Healthy Human Body. J. Breath Res. 2014, 8 (1), 014001. DOI: 10.1088/1752-7155/8/1/014001
3. Haworth, J. J.; Pitcher, C. K.; Ferrandino, G.; Hobson, A. R.; Pappan, K. L.; Lawson, J. L. D. Breathing New Life into Clinical Testing and Diagnostics: Perspectives on Volatile Biomarkers from Breath. Crit. Rev. Clin. Lab. Sci. 2022, 59 (5), 353–372. DOI: 10.1080/10408363.2022.203807
4. Issitt, T.; Wiggins, L.; Veysey, M.; Sweeney, S. T.; Brackenbury, W. J.; Redeker, K. Volatile Compounds in Human Breath: Critical Review and Meta-Analysis. J. Breath Res. 2022, 16 (2), 024001. DOI: 10.1088/1752-7163/ac5230
5. Jia, Z.; Patra, A.; Kutty, V. K.; Venkatesan, T. Critical Review of Volatile Organic Compound Analysis in Breath and in vitro Cell Culture for Detection of Lung Cancer. Metabolites 2019, 9 (3), 52. DOI: 10.3390/metabo9030052
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.